¿Cuál es la utilidad del bloqueo de  interleuquina-6 en pacientes con  COVID-19?

Angriman, Federico

¿Cuál es la utilidad del bloqueo de interleuquina-6 en pacientes con COVID-19? / What is the use of blocking interleukin-6 in patients with COVID-19?

Angriman, Federico.

Angriman, Federico; University of Toronto. Sunnybrook Health Sciences Centre Interdepartmental Division of Critical Care Medicine. Department of Critical Care Medicine. Toronto. CA

Rev. Hosp. Ital. B. Aires (2004) ; 41(4): 193-195, dic. 2021. tab

Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1367011

Subject(s)

Humans; Interleukin-6/immunology; COVID-19/therapy; Interleukin-6/pharmacokinetics; Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19/prevention & control

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Interleukin-6 / COVID-19 Limits: Humans Language: Spanish Journal: Rev. Hosp. Ital. B. Aires (2004) Year: 2021 Type: Article Institution/Affiliation country: University of Toronto/CA

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google